Tech Company Financing Transactions

Lumos Pharma Funding Round

On 4/6/2016, Lumos Pharma landed $34 million in Series B funding from Deerfield Capital, Clarus and New Enterprise Associates.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

4200 Marathon Blvd. 200
Austin, TX 78756
USA

Phone

(512) 215-2630

Website

www.lumos-pharma.com

Email Address

[email protected]

Overview

Lumos Pharma, based in Austin, Texas, is an early stage biotechnology company created to develop and commercialize a novel treatment for the rare disease Creatine Transporter Deficiency.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Rick Hawkins

        

Chief Financial Officer

Carl Langren

        

Chief Medical Officer

Eugene Kennedy

        

Chief Operating Officer

John McKew

        

VP - Bus. Development

Aaron Schuchart

        

VP - Finance

Lori Lawley

        

VP - General Counsel

Brad Powers

        

Browse more venture capital transactions:

Prev: 4/6/2016: Cortera venture capital transaction
Next: 4/6/2016: Tablelist venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary